Qingdao Gaiersapu Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Qingdao Gaiersapu Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RED SACRE. The owner is based in Qingdao City, Shandong Province.

Room A17, 15th Floor, No. 30, Hong Kong Middle Road, Shinan District

Qingdao City, Shandong Province 266000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RED SACRE
RED SACRE
Registered 2025

Trademark Classifications

Qingdao Gaiersapu Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Qingdao Gaiersapu Biotechnology Co., Ltd. have?

Qingdao Gaiersapu Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Qingdao Gaiersapu Biotechnology Co., Ltd. file in?

Qingdao Gaiersapu Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Qingdao Gaiersapu Biotechnology Co., Ltd.'s most well-known trademarks?

Qingdao Gaiersapu Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as RED SACRE. These are among 1 currently registered trademark in the portfolio.

What is Qingdao Gaiersapu Biotechnology Co., Ltd.'s trademark registration success rate?

Qingdao Gaiersapu Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.